Showing results (21-30 of 64) with videos related to
Sort By:
Pageof 7
Journal of Clinical Gastroenterology|March 29, 2021
Estimate of Refractory Reflux Disease in the United States: Economic Burden and Associated Clinical CharacteristicsColin W Howden, Machelle Manuel, Douglas Taylor, et al.Applied Health Economics and Health Policy|July 23, 2013
Cost effectiveness of denosumab versus oral bisphosphonates for postmenopausal osteoporosis in the USAnju Parthan, Morgan Kruse, Nicole Yurgin, et al.Contraception|March 15, 2006
Bleeding patterns after use of levonorgestrel emergency contraceptive pillsElizabeth G Raymond, Alisa Goldberg, James Trussell, et al.The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|January 6, 2016
Cost-effectiveness of linaclotide compared to antidepressants in the treatment of irritable bowel syndrome with constipation in ScotlandMark Fisher, Andrew Walker, Meritxell Falqués, et al.Contraception: X|October 12, 2023
A randomized crossover study to evaluate local tolerability following subcutaneous administration of a new depot medroxyprogesterone acetate contraceptive formulationVera Halpern, Angie Wheeless, Vivian Brache, et al.Fertility and Sterility|January 24, 2021
Clinical trial to evaluate pharmacokinetics and pharmacodynamics of medroxyprogesterone acetate after subcutaneous administration of Depo-ProveraVera Halpern, Vivian Brache, Douglas Taylor, et al.Transfusion|August 1, 2012
Coagulation profile of liquid-state plasmaRobert C Gosselin, Carol Marshall, Denis M Dwyre, et al.Contraception: X|September 30, 2020
Levonorgestrel release rates measured through analysis of two-rod contraceptive explantsRachael Fuchs, Douglas Taylor, David W Jenkins, et al.Contraception|March 15, 2016
Medroxyprogesterone acetate levels among Kenyan women using depot medroxyprogesterone acetate in the FEM-PrEP trialKavita Nanda, Rebecca Callahan, Douglas Taylor, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|January 16, 2015
Pregnancy and contraceptive use among women participating in the FEM-PrEP trialRebecca Callahan, Kavita Nanda, Saidi Kapiga, et al.Pageof 7